Predictions
Moderna Inc.
Start price
Target price
Perf. (%)
€137.82
13.10.22
13.10.22
-
13.10.23
13.10.23
5.79%
23.02.23
23.02.23
Significant cyclical dependencies
Higher risks for its business
Blueprint Medicines Corp
Start price
Target price
Perf. (%)
€74.46
07.09.22
07.09.22
€100.00
31.12.24
31.12.24
-29.49%
05.05.23
05.05.23
Could be very worthwhile Investment >20% year
Alnylam Pharmace.
Start price
Target price
Perf. (%)
€208.80
07.09.22
07.09.22
€300.00
31.12.24
31.12.24
12.88%
08.07.24
08.07.24
Could be very worthwhile Investment >20% year
Mirati Therapeutics Inc.
Start price
Target price
Perf. (%)
€76.50
21.08.22
21.08.22
€230.00
21.08.23
21.08.23
6.54%
04.09.22
04.09.22
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Probably not worthwhile Investment
Lower EBIT Margin than peer group
Alnylam Pharmace.
Start price
Target price
Perf. (%)
€214.90
21.08.22
21.08.22
€87.00
21.08.23
21.08.23
-3.44%
04.09.22
04.09.22
Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
PTC Therapeutics Inc.
Start price
Target price
Perf. (%)
€51.50
16.08.22
16.08.22
-
16.08.23
16.08.23
-27.77%
16.08.23
16.08.23
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€104.86
16.08.22
16.08.22
-
16.08.23
16.08.23
-6.73%
16.08.23
16.08.23
Global Blood Therapeutics Inc
Start price
Target price
Perf. (%)
€64.36
10.08.22
10.08.22
-
10.08.23
10.08.23
6.49%
10.08.23
10.08.23
Amicus Therapeutics Inc.
Start price
Target price
Perf. (%)
€12.10
10.08.22
10.08.22
-
10.08.23
10.08.23
3.34%
10.08.23
10.08.23
Zoom Video Communications Inc
Start price
Target price
Perf. (%)
€103.16
09.08.22
09.08.22
€60.00
09.08.23
09.08.23
-32.10%
13.02.23
13.02.23
Top 10 in its market
Future proof or reliable business model
negative Cash Flow expected
Significant cyclical dependencies
Amc Networks Inc. A
Start price
Target price
Perf. (%)
€29.14
08.08.22
08.08.22
-
08.08.23
08.08.23
-57.79%
09.08.23
09.08.23
Revenue decline/stagnation expected
Little Investments for future growth
Risky balance sheet
Sustainability is little important
Bath & Body Works Inc.
Start price
Target price
Perf. (%)
€33.43
27.07.22
27.07.22
€25.00
27.07.23
27.07.23
13.67%
04.08.22
04.08.22
Probably not worthwhile Investment
Significant cyclical dependencies
Tapestry Inc.
Start price
Target price
Perf. (%)
€32.73
27.07.22
27.07.22
€25.00
27.07.23
27.07.23
17.32%
25.05.23
25.05.23
Probably not worthwhile Investment
Significant cyclical dependencies
Gaming & Leisure Properties
Start price
Target price
Perf. (%)
€49.80
26.07.22
26.07.22
-
26.07.23
26.07.23
-11.37%
26.07.23
26.07.23
DocuSign Inc.
Start price
Target price
Perf. (%)
€65.70
21.07.22
21.07.22
€50.00
21.07.23
21.07.23
-29.37%
22.07.23
22.07.23
Probably not worthwhile Investment
EBIT decline/stagnation expected
High valuation
Very low/no dividend yield expected
Zillow Group Inc
Start price
Target price
Perf. (%)
€36.83
21.07.22
21.07.22
€49.00
21.07.23
21.07.23
24.44%
22.07.23
22.07.23
Probably not worthwhile Investment
Lower EBIT Margin than peer group
Very low/no dividend yield expected
Below average Management